WO2002017911A1 - Inhibiteurs de la production de parathormone contenant des derives de vitamine d3 - Google Patents
Inhibiteurs de la production de parathormone contenant des derives de vitamine d3 Download PDFInfo
- Publication number
- WO2002017911A1 WO2002017911A1 PCT/JP2001/007431 JP0107431W WO0217911A1 WO 2002017911 A1 WO2002017911 A1 WO 2002017911A1 JP 0107431 W JP0107431 W JP 0107431W WO 0217911 A1 WO0217911 A1 WO 0217911A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- hyperparathyroidism
- pth
- above formula
- parathyroid hormone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01963393A EP1321141A4 (en) | 2000-08-30 | 2001-08-29 | INHIBITORS OF PARATHORMONE PRODUCTION CONTAINING VITAMIN D3 DERIVATIVES |
AU2001284412A AU2001284412A1 (en) | 2000-08-30 | 2001-08-29 | Parathyroid hormone production inhibitors containing vitamin D3 derivatives |
US10/362,289 US20050101574A1 (en) | 2000-08-30 | 2001-08-29 | Parathyroid hormone production inhibitors containing vitamin d3 derivatives |
CA002420759A CA2420759A1 (en) | 2000-08-30 | 2001-08-29 | Parathyroid hormone production inhibitors containing vitamin d3 derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-260582 | 2000-08-30 | ||
JP2000260582 | 2000-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002017911A1 true WO2002017911A1 (fr) | 2002-03-07 |
Family
ID=18748569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/007431 WO2002017911A1 (fr) | 2000-08-30 | 2001-08-29 | Inhibiteurs de la production de parathormone contenant des derives de vitamine d3 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20050101574A1 (ja) |
EP (1) | EP1321141A4 (ja) |
AU (1) | AU2001284412A1 (ja) |
CA (1) | CA2420759A1 (ja) |
WO (1) | WO2002017911A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003070716A1 (fr) * | 2002-02-20 | 2003-08-28 | Teijin Limited | Derives de vitamine d3 et medicaments les utilisant |
JP2006503880A (ja) * | 2002-10-23 | 2006-02-02 | レオ・ファーマ・アクティーゼルスカブ | ビタミンd類似体、該類似体を含んで成る組成物およびその使用 |
WO2014092061A1 (ja) * | 2012-12-10 | 2014-06-19 | 中外製薬株式会社 | ヒダントイン誘導体 |
US9487517B2 (en) | 2009-04-28 | 2016-11-08 | Chugai Seiyaku Kabushiki Kaisha | Spiroimidazolone derivative |
US9993462B2 (en) | 2014-06-09 | 2018-06-12 | Chugai Seiyaku Kabushiki Kaisha | Hydantoin derivative-containing pharmaceutical composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0625155A (ja) * | 1992-03-02 | 1994-02-01 | Kuraray Co Ltd | 22−メチルビタミンd誘導体 |
JPH07330713A (ja) * | 1994-06-13 | 1995-12-19 | Kuraray Co Ltd | 22−アルキル−25,26,27−トリスノルビタミンd誘導体 |
JPH1135470A (ja) * | 1997-07-23 | 1999-02-09 | Teijin Ltd | ビタミンd3誘導体を含有する副甲状腺ホルモン産生促進剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4948789A (en) * | 1989-03-28 | 1990-08-14 | Chugai Seiyaku Kabushiki Kaisha | Suppression of parathyroid hormone synthesis and secretion |
EP0712843B1 (en) * | 1994-06-07 | 1999-11-17 | Teijin Limited | Vitamin d3 derivative and process for producing the same |
US5597815A (en) * | 1995-07-13 | 1997-01-28 | Wisconsin Alumni Research Foundation | Prevention of hyperphosphatemia in kidney disorder patients |
US6531460B1 (en) * | 1998-10-23 | 2003-03-11 | Teijin Limited | Vitamin D, derivatives and remedies for inflammatory respiratory diseases containing the same |
-
2001
- 2001-08-29 US US10/362,289 patent/US20050101574A1/en not_active Abandoned
- 2001-08-29 AU AU2001284412A patent/AU2001284412A1/en not_active Abandoned
- 2001-08-29 EP EP01963393A patent/EP1321141A4/en not_active Withdrawn
- 2001-08-29 CA CA002420759A patent/CA2420759A1/en not_active Abandoned
- 2001-08-29 WO PCT/JP2001/007431 patent/WO2002017911A1/ja not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0625155A (ja) * | 1992-03-02 | 1994-02-01 | Kuraray Co Ltd | 22−メチルビタミンd誘導体 |
JPH07330713A (ja) * | 1994-06-13 | 1995-12-19 | Kuraray Co Ltd | 22−アルキル−25,26,27−トリスノルビタミンd誘導体 |
JPH1135470A (ja) * | 1997-07-23 | 1999-02-09 | Teijin Ltd | ビタミンd3誘導体を含有する副甲状腺ホルモン産生促進剤 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1321141A4 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003070716A1 (fr) * | 2002-02-20 | 2003-08-28 | Teijin Limited | Derives de vitamine d3 et medicaments les utilisant |
JP2006503880A (ja) * | 2002-10-23 | 2006-02-02 | レオ・ファーマ・アクティーゼルスカブ | ビタミンd類似体、該類似体を含んで成る組成物およびその使用 |
US9487517B2 (en) | 2009-04-28 | 2016-11-08 | Chugai Seiyaku Kabushiki Kaisha | Spiroimidazolone derivative |
WO2014092061A1 (ja) * | 2012-12-10 | 2014-06-19 | 中外製薬株式会社 | ヒダントイン誘導体 |
JP5951799B2 (ja) * | 2012-12-10 | 2016-07-13 | 中外製薬株式会社 | ヒダントイン誘導体 |
US9428505B2 (en) | 2012-12-10 | 2016-08-30 | Chugai Seiyaku Kabushiki Kaisha | Hydantoin derivative |
US9993462B2 (en) | 2014-06-09 | 2018-06-12 | Chugai Seiyaku Kabushiki Kaisha | Hydantoin derivative-containing pharmaceutical composition |
Also Published As
Publication number | Publication date |
---|---|
EP1321141A4 (en) | 2004-02-18 |
EP1321141A1 (en) | 2003-06-25 |
CA2420759A1 (en) | 2003-02-27 |
AU2001284412A1 (en) | 2002-03-13 |
US20050101574A1 (en) | 2005-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111936127A (zh) | 炎症性疾病或骨病的预防或治疗剂及医药组合物 | |
Rizzoli et al. | Role of bone and kidney in parathyroid hormone‐related peptide‐induced hypercalcemia in rats | |
JP2001515864A (ja) | 非天然fp選択的作用薬を使用した骨体積増加方法 | |
US11291681B2 (en) | Method for treating fibrotic liver tissue using Cl-IB-MECA | |
EP2263677B1 (en) | New therapeutical uses of inecalcitol | |
SK1702004A3 (sk) | Farmaceutický prostriedok na liečenie diabetu, jeho použitie a súprava obsahujúca tento prostriedok | |
JP2003508435A (ja) | インスリン抵抗性の治療薬を製造するためのアミノ酸の使用 | |
JP2684587B2 (ja) | 腎性骨異栄養症における骨量減少抑制剤 | |
WO2002017911A1 (fr) | Inhibiteurs de la production de parathormone contenant des derives de vitamine d3 | |
US7319095B2 (en) | Use of GABAB receptor agonists | |
US7214671B2 (en) | Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases | |
JPH0780773B2 (ja) | 新規ビタミンd▲下3▼誘導体を有効成分とする医薬 | |
JP2008530121A (ja) | 多発性硬化症を治療および予防するためのカルシトニンおよびカルシトニン様ペプチド類の使用 | |
Maeda et al. | Possible mechanism for pharmacokinetic interaction between lidocaine and mexiletine | |
WO2003013546A1 (fr) | Agent hypoglycemiant | |
EP3796901A2 (en) | Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease | |
JP2002069003A (ja) | ビタミンd誘導体を含有する骨吸収抑制剤 | |
JPH1135470A (ja) | ビタミンd3誘導体を含有する副甲状腺ホルモン産生促進剤 | |
US11980595B2 (en) | Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases | |
SK3402000A3 (en) | Use of a substance primary activating the osteoblastic protein kinase c/intracellular calcium pathways of a subject | |
JPWO2003004036A1 (ja) | 二次性副甲状腺機能亢進症の治療用医薬組成物および二次性副甲状腺機能亢進症治療に伴う心血管系合併症の治療薬 | |
Naveh-Many et al. | Vitamin D analogs for the treatment of secondary hyperparathyroidism in chronic renal failure | |
JPH0347127A (ja) | 副甲状腺機能亢進症治療剤 | |
WO2006071185A1 (en) | New use of gabab receptor agonists | |
JP2002538122A (ja) | 天然に存在しないfp選択的アゴニストおよび骨吸収抑制化合物を用いる骨体積の増加方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001284412 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10362289 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2420759 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001963393 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001963393 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001963393 Country of ref document: EP |